Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms.
Senapati J, Loghavi S, Garcia-Manero G, Tang G, Kadia T, Short NJ, Abbas HA, Arani N, DiNardo CD, Borthakur G, Pemmaraju N, Oran B, Shpall E, Popat U, Champlin R, Pierce S, Arora S, Issa G, Yilmaz M, Patel K, Takahashi K, Montalban-Bravo G, Hammond D, Haddad FG, Ravandi F, Kantarjian HM, Daver NG.
Senapati J, et al. Among authors: hammond d.
Haematologica. 2024 Dec 12. doi: 10.3324/haematol.2024.286465. Online ahead of print.
Haematologica. 2024.
PMID: 39665206
Free article.